Beckley Waves
Beckley Waves is a psychedelic-focused venture studio that co-founds, incubates, and invests in companies building care delivery infrastructure for psychedelic-assisted therapies, spanning clinical services, retreats, practitioner training, digital wellbeing, and mental health support globally.
- Company typePrivate
- Founded2020
- HeadquartersBeckley, United Kingdom
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Beckley Waves does
Beckley Waves is a private venture studio and holding company founded in 2020 by Amanda Feilding, Rock Feilding-Mellen, and Daniel Love to build the care delivery infrastructure for psychedelic-assisted therapies. Operating as a holding company, it co-founds, incubates, and invests in companies that address how psychedelic and adjacent therapies reach people safely, effectively, and at scale — a structural gap left by capital concentrated in research and drug development. Its portfolio spans the full care continuum: Beckley Clinical (interventional psychiatry care delivery and reimbursement), Beckley Retreats (legal psychedelic wellbeing programs), Beckley Academy (practitioner training and certification), Lumenate (digital at-home wellbeing app using sensory entrainment), Homecoming (integration support platform for clinics and retreats), and Sanarte (concierge family-centered mental health). The company also owns and operates The Trip Report, a newsletter and podcast covering psychedelic business, science, and policy.
Commercially, Beckley Waves generates returns through equity ownership in portfolio companies rather than direct product sales. Revenue mechanics span cash-pay clinical services (Beckley Clinical), retreat programs (Beckley Retreats), subscriptions and consumer transactions in digital wellness (Lumenate), training program fees (Beckley Academy), and SaaS-style tooling for practitioners (Homecoming). The company participates in a broader Beckley ecosystem that includes the Beckley Foundation (research and policy) and Beckley Psytech, the drug development pillar that merged into Atai Beckley Inc in November 2025. Beckley Waves raised a $3.3 million seed round in September 2023 from 1440 Foundation, Bridge Builders Collaborative, Evolve Ventures, FJ Labs, Samberg Foundation, and Satori Capital, and acquired Nue Life Health in October 2023, adding more than 100,000 cumulative ketamine experiences to the platform.
Beckley Waves firmographics
Firmographics- Name
- Beckley Waves
- Legal name
- Beckley Waves
- Website
- https://beckleywaves.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Beckley Waves is a psychedelic-focused venture studio that co-founds, incubates, and invests in companies building care delivery infrastructure for psychedelic-assisted therapies, spanning clinical services, retreats, practitioner training, digital wellbeing, and mental health support globally.
- Ownership category
- akta.pro rank
Beckley Waves industry classification
Industry- Product category
- Psychedelic Care Venture Studio
- NAICS
- Offices of Physicians, Mental Health Specialists (621112)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Peer Support, Recovery Coaching & Sober Living Services (HLAFACAN)
- akta.pro secondary industries
- Meditation Retreats, Workshops & Immersive Programs (HSADAJAF), Holistic & Alternative Therapy Retreats (Naturopathy, Energy Work) (THAGAMAI), Mindfulness & Mental Wellbeing Experiences (Stress Management, Sleep Retreats, Coaching) (THAJAHAH), Recreation Therapy, Stress Management & Mindfulness Programs (EDALAFAO)
Keywords
Where Beckley Waves is headquartered
LocationHeadquarters
- HQ city
- Beckley
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Beckley Waves business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Venture Studio and Investment Returns: Beckley Waves operates as a venture studio that generates returns through equity ownership in portfolio companies it co-founds and incubates. The company invests in early-stage companies developing infrastructure and services for psychedelic therapies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Beckley Waves product offering
Product offeringCore offering
Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds, incubates, or invests in companies building the operational infrastructure for safe, legal, and effective delivery of psychedelic-assisted therapies. Its portfolio covers clinical interventional psychiatry (Beckley Clinical), guided psychedelic wellbeing programs (Beckley Retreats), practitioner training (Beckley Academy), digital at-home neuro-entrainment experiences (Lumenate), therapist/clinic integration software (Homecoming), and concierge family-centered mental health (Sanarte). The company also publishes The Trip Report newsletter and podcast covering psychedelic business, science, and policy.
Product overview
Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds and invests in companies to build the operational infrastructure for the global psychedelic ecosystem. The portfolio includes Beckley Clinical (interventional psychiatry care delivery), Beckley Retreats (legal psychedelic wellbeing programs), Beckley Academy (professional training for practitioners), Lumenate (digital at-home wellness platform), Homecoming (integration support platform), Sanarte (concierge family-centered mental health), and The Trip Report (industry newsletter and podcast).
Differentiator
Problem solved
Functional benefit
Brands
- The Trip Report: Newsletter and podcast covering the business, science, and policy developments of the evolving psychedelic field
- Beckley Clinical
- Beckley Retreats
- Beckley Academy
Products and services
- Beckley Clinical Behavioral health innovation company delivering evidence-based, personalized treatment solutions for hard-to-treat conditions, focused on building care delivery and reimbursement models for interventional psychiatry in the United States.
- Beckley Retreats Provider of legal psychedelic wellbeing programs offering guided psychedelic experiences in safe, lawful settings, blending modern science with indigenous practices to support health and human flourishing beyond traditional medical models.
- Beckley Academy World-class training program and professional network educating, training, and certifying therapists, practitioners, and facilitators to deliver safe, ethical, and legal psychedelic-assisted therapies.
- Lumenate Digital platform offering accessible at-home experiences for meditation, insight, and expanded awareness via a smartphone-enabled app using scientifically calibrated flashing light (sensory entrainment) to guide users into neural states optimized for subconscious exploration.
- Homecoming SaaS platform partnering with psychedelic therapists, clinics, and retreats to support clients before, between, and after sessions through personalized tasks, guides, daily check-ins, data analytics, and a practitioner growth/patient-referral network.
- Sanarte Concierge mental health service championing a wellness approach emphasizing relationships and family-centered care, delivering comprehensive integrated specialist services with holistic, evidence-based practices for enduring positive outcomes.
Quantifiable outcome
- 100,000+ ketamine experiences facilitated through acquired portfolio company Nue Life Health
Companies that use Beckley Waves
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Beckley Waves technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Beckley Waves partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Beckley FoundationcoreNon-profit, non-governmental organization and think tank that initiates, funds, and supports scientific research driving adoption of evidence-based psychedelic therapies and drug-policy reforms globally. Sister organization with shared belief in transformative potential of psychedelics and common goal of ethical leadership in the psychedelic ecosystem.
- Beckley Psytech (now Atai Beckley Inc)coreDrug development company advancing psychedelic medicines to unlock therapeutic potential at scale. Merged into Atai Beckley Inc in November 2025. Part of the broader Beckley ecosystem focused on drug development complementing Beckley Waves' care delivery focus.
- Beckley ClinicalcorePortfolio company leading in behavioral health innovation, committed to delivering transformative health outcomes through evidence-based, personalized treatment solutions for hard-to-treat conditions. Focus on care delivery and reimbursement for interventional psychiatry.
- Beckley RetreatscorePortfolio company providing legal psychedelic wellbeing programs with world-class facilitators blending modern science and indigenous practices for guided psychedelic experiences in safe, lawful settings.
- Beckley AcademycorePortfolio company providing world-class training program and professional network for therapists, practitioners, and facilitators working to meet growing demand for safe, ethical, legal psychedelic-assisted therapies.
- LumenateminorPortfolio company offering digital platform with smartphone-enabled app using sensory entrainment through flashing light to activate neurons for subconscious exploration, meditation, and expanded awareness.
- HomecomingminorPortfolio company partnering with psychedelic therapists, clinics, and retreats to support clients before, between, and after sessions with personalized tasks, guides, daily check-ins, and practitioner growth tools.
- SanarteminorPortfolio company providing pioneering concierge mental health services with family-centered care approach, integrated specialist teams, and holistic evidence-based practices for enduring positive outcomes.
- Nue Life HealthminorAcquired company that had facilitated over 100,000 ketamine experiences. Represents Beckley Waves' acquisition strategy for building at-home ketamine therapy capabilities as market shifts from brick-and-mortar clinics to scalable, technology-enabled home-based care models.
Scale indicators4 records
Recent moves5 records
Expansion highlights6 records
Beckley Waves competitors and assessment
Company assessmentBroad incumbents
- ATAI Life Sciences: Public psychedelic mental-health platform and parent of Atai Beckley Inc. Directly comparable as a sister entity in the Beckley ecosystem, with overlapping psychedelic therapy focus but a drug-development (rather than care-delivery) orientation.
- Compass Pathways: Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Comparable as a leading investor in psychedelic-assisted therapy infrastructure, though focused on drug development rather than care-delivery models.
- MindMed: Public clinical-stage psychedelic medicine company developing LSD and MDMA-based therapies. Comparable as a peer in the psychedelic mental-health ecosystem with parallel drug-development and digital-health ambitions.
Direct peers
- Numinus Wellness: Public Canadian company operating psychedelic therapy clinics and a research division. Closely comparable to Beckley Waves as a care-delivery operator with clinical, wellness, and research arms spanning ketamine and psilocybin-assisted therapy.
- Field Trip Health (defunct): Operated psychedelic-assisted therapy clinics across North America and Europe before winding down. Most directly comparable historical peer to Beckley Clinical/Beckley Retreats for the clinic-and-wellness care-delivery model.
- Novamind (formerly Mydecine): Public psychedelic mental-health company operating ketamine-assisted therapy clinics and research sites. Comparable as a peer in the psychedelic clinic and care-delivery space, particularly to Beckley Clinical.
Emerging players
- GH Research: Public clinical-stage company developing mebufotenin (5-MeO-DMT) therapies for depression. Comparable as a psychedelic-focused peer, though narrower drug-development orientation versus Beckley Waves' diversified studio approach.
- Cybin Inc: Public clinical-stage psychedelic company developing psilocybin analogs and deuterated DMT. Comparable as a peer pursuing psychedelic therapy development with adjacent digital-support offerings (like Beckley Waves' Homecoming).
- Delix Therapeutics: Clinical-stage biotech developing non-hallucinogenic psychedelic-inspired medicines. Comparable as a peer addressing mental-health via psychedelic-adjacent approaches, though Delix is purely drug-development.
Regional players
- Beehive Healthcare / Ketamine Clinic peers (e.g., Klarity, Joyous): At-home ketamine therapy platforms with similar care-delivery models to Beckley's inherited Nue Life business. Comparable as direct peers in the home-based ketamine treatment market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Beckley Waves social profiles
Digital presenceBeckley Waves financial estimates
Financial estimateRevenue estimate
Valuation estimate
Beckley Waves leadership team
Management profileNumber of profiles
Profiles5 records
Beckley Waves subsidiaries and ownership
Company hierarchySubsidiaries4 records
Beckley Waves funding detail
Funding detailFunding overview
Funding rounds1 record
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Beckley Waves M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Beckley Waves
What does Beckley Waves do?
Beckley Waves is a psychedelic venture studio structured as a holding company that co-founds, incubates, or invests in companies building the operational infrastructure for safe, legal, and effective delivery of psychedelic-assisted therapies. Its portfolio covers clinical interventional psychiatry (Beckley Clinical), guided psychedelic wellbeing programs (Beckley Retreats), practitioner training (Beckley Academy), digital at-home neuro-entrainment experiences (Lumenate), therapist/clinic integration software (Homecoming), and concierge family-centered mental health (Sanarte). The company also publishes The Trip Report newsletter and podcast covering psychedelic business, science, and policy.
Is Beckley Waves a public or private company?
Beckley Waves is a private company. It is classified as venture growth investor backed and is currently operating.
When was Beckley Waves founded?
Beckley Waves was founded in 2020. It employs 1 to 10 people.
Where is Beckley Waves based?
Beckley Waves is headquartered in Beckley, United Kingdom, in the Europe region.
How does Beckley Waves make money?
One revenue line is on record: venture Studio and Investment Returns.
Who are Beckley Waves's main competitors?
Broad incumbents on record are ATAI Life Sciences, Compass Pathways and MindMed. Direct peers are Numinus Wellness, Field Trip Health (defunct) and Novamind (formerly Mydecine). Emerging players are GH Research, Cybin Inc and Delix Therapeutics. Beehive Healthcare / Ketamine Clinic peers (e.g., Klarity, Joyous) is listed as a regional player.
Does Beckley Waves have an API?
No public API is recorded for Beckley Waves.
What industry is Beckley Waves in?
Beckley Waves's product category is Psychedelic Care Venture Studio. Its primary akta.pro industry code is HLAFACAN, Peer Support, Recovery Coaching & Sober Living Services, with a secondary code of HSADAJAF, Meditation Retreats, Workshops & Immersive Programs. Its NAICS code is 621112 and its SIC code is 8000.